NLS Collaboration

Elypta has announced its role as a main partner in PREDI-LYNCH, a European initiative aimed at transforming early cancer detection for individuals with Lynch Syndrome (LS).

The two companies have announced an exclusive global collaboration and license agreement to discover, develop and commercialize oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.

This collaboration represents a powerful alignment of capabilities designed to address the growing complexity of global regulatory requirements, the companies state.

The company has announced a new collaboration focused on developing antibody-based therapies for acute and critical care of cardiovascular disease.

Circio Holding (former Targovax) and Entos Pharmaceuticals have announced the initiation of a research collaboration.

These partnerships are part of ContextVision’s broader strategy to engage with global ultrasound players, securing additional expertise and analytical support, and to drive advancements in data quality and clinical applications for ultrasound-based solutions.